MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March. This data was drawn from dicardiology.com’s 163,000 viewers over the course of the month.

1. FDA Recalls Quinapril Hydrochloride and Hydrochlorothiazide Tablets by Pfizer

2. David Bennett, Pig Heart Transplant Patient, Dies

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held April 3-5 at the Bella Center in Copenhagen, Denmark and online. Explore the scientific program.

March 31, 2022 – Investigators from Cedars-Sinai have created an artificial intelligence-enabled tool that may make it easier to predict if a person will have a heart attack.

March 31, 2022 – DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software, announced today a multi-year agreement with Change Healthcare, a global industry-leading provider of enterprise imaging solutions.

March 31, 2022 – Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has successfully completed enrollment in its phase 2 study of istaroxime in early cardiogenic shock caused by heart failure.

March 31, 2022 – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the publication of results from the first-in-human clinical trial of Embrace Hydrogel Embolic System (HES) for the

March 31, 2022 – Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the first patient was treated in a U.S. early feasibility study evaluating PerQseal+, the next generation of the company’s PerQseal device.

March 31, 2022 – One in 5 people worldwide have high Lipoprotein(a) – sometimes referred to as “L-P-little a” – an important genetic risk factor for premature heart disease and stroke. If you have a family history of early heart disease or have been told that heart disease “runs in your family,” but you’ve never been told why, it’s important to know if you have high Lp(a).

March 31, 2022 – People living in socially-deprived areas of the United States are more likely to die prematurely from cardiovascular (CV) complications according to new research published recently in Mayo Clinic Proceedings. The study, completed by researchers at University Hospitals (UH) Harrington Heart &am

 March 31, 2022 – A study conducted at São Paulo State University (UNESP) in Brazil shows that even mild to moderate infection by SARS-CoV-2 can cause an imbalance in the cardiovascular system of young adults without pre-existing diseases.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now